Kenya - English - Pharmacy and Poisons Board

cintana healthcare ltd p. o. box 45214 gpo - amoxicillin trihydrate potassium clavulanate - dispersible tablet - amoxicillin 200 mg potassium clavulanate 28.5 mg - amoxicillin and enzyme inhibitor

Kenya - English - Pharmacy and Poisons Board

amoxicillin trihydrate, potassium clavulanate - tablet - amoxicillin trihydrate equivalent to amoxicillin… - amoxicillin and enzyme inhibitor

Canada - English - Health Canada

teva canada limited - clavulanic acid (potassium clavulanate); amoxicillin (amoxicillin trihydrate) - tablet - 125mg; 500mg - clavulanic acid (potassium clavulanate) 125mg; amoxicillin (amoxicillin trihydrate) 500mg - aminopenicillins

Kenya - English - Pharmacy and Poisons Board

chiros pharma village loharon, p.o. ghatti, distt. solan, (hp) - amoxicillin trihydrate and potassium clavulanate - dispersible tablet - amoxicillin 200mg + potassium clavulanate 28.5mg… - amoxicillin and enzyme inhibitor

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - amoxicillin trihydrate 573.96mg equivalent to amoxicillin 500 mg;  ; potassium clavulanate 148.91mg equivalent to clavulanic acid 125 mg;   - film coated tablet - 500mg/125mg - active: amoxicillin trihydrate 573.96mg equivalent to amoxicillin 500 mg   potassium clavulanate 148.91mg equivalent to clavulanic acid 125 mg   excipient: colloidal silicon dioxide dimeticone hypromellose macrogol 4000 macrogol 6000 magnesium stearate microcrystalline cellulose opadry white oy-s-7300 as an alternative source of film coat sodium starch glycolate titanium dioxide - augmentin should be used in accordance with local official antibiotic prescribing guidelines and local susceptibility data. augmentin is indicated for the short term treatment of common bacterial infections in adults and children such as: upper respiratory tract infections (including ent): e.g. tonsillitis, sinusitis, otitis media lower respiratory tract infections: e.g. acute exacerbations of chronic bronchitis, lobar and broncho pneumonia genito-urinary tract infections: e.g. cystitis, urethritis, pyelonephritis, female genital infections skin and soft tissue infections bone and joint infections: e.g. osteomyelitis other infections: e.g. septic abortion, puerperal sepsis, intra-abdominal sepsis, septicaemia, peritonitis, post-surgical infections susceptibility to augmentin will vary with geography and time. local susceptibility data should be consulted where available, and microbiological sampling and susceptibility testing performed where necessary. infections caused by amoxicillin susceptible organisms are amenable to augmentin treatment due to its amoxicillin content. mixed infections caused by amoxicillin susceptible organism in conjunction with augmentin susceptible beta-lactamase-producing organisms may therefore be treated by augmentin.

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - amoxicillin trihydrate; potassium clavulanate & avicel (1:1) ph. eur. equivalent to clavulanic acid - film-coated tablet - 875/125 milligram(s) - combinations of penicillins, incl. beta-lactamase inhibitors; amoxicillin and enzyme inhibitor

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

ranbaxy (malaysia) sdn. bhd. - amoxicillin trihydrate; potassium clavulanate -

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - potassium clavulanate, quantity: 149.774 mg (equivalent: clavulanic acid, qty 125 mg); amoxicillin trihydrate, quantity: 1012.617 mg (equivalent: amoxicillin, qty 875 mg) - tablet, film coated - excipient ingredients: magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; sodium starch glycollate type a; dichloromethane; isopropyl alcohol; titanium dioxide; hypromellose; purified talc; diethyl phthalate; ethylcellulose - clavam tablets are indicated for short term treatment of bacterial infections at the following sites when caused by sensitive organisms (refer to microbiology):,urinary tract infections (uncomplicated and complicated), lower respiratory tract infections, including community acquired pneumonia and acute exacerbations of chronic bronchitis, upper respiratory tract infections, such as sinusitis, otitis media and recurrent tonsillitis.skin and skin structure infection.,appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to clavam tablets. however, when there is reason to believe an infection may involve any of the beta-lactamase producing organisms listed above, therapy may be instituted prior to obtaining the results from bacteriological and susceptibility studies. once these results are known, therapy should be adjusted if appropriate.,the treatment of mixed infections caused by amoxycillin susceptible organisms and beta-lactamase producing organisms susceptible to clavam tablets should not require the addition of another antibiotic due to the amoxycillin content of these products.

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

smithkline beecham limited - amoxicillin (amoxicillin trihydrate), clavulanic acid (potassium clavulanate) - tablets film-coated - 250mg+ 125mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

smithkline beecham limited - amoxicillin (amoxicillin trihydrate), clavulanic acid (potassium clavulanate) - powder for oral suspension - 125mg/5ml+ 31,25mg/5ml